JBT Marel 3Q 2026: Revenue $994M, EPS $1.34— 10-Q Summary

JBT Marel reported Q3 2026 revenue of $994M, down 0.7% YoY, while net income rose 6.1% to $70M and EPS increased 6.3% to $1.34. Nine-month revenue grew 4.3%, with Protein Solutions up 12.6% and Prepared Food and Beverage down 2.3%. The company expects full-year growth in revenue, margins, and EPS.

Original reporting
Published Nov 3, 2026, 10:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 10:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
JBT Marel 3Q 2026: Revenue $994M, EPS $1.34— 10-Q Summary — source image
Decision brief

The 30-second read

$JBTMNeutralMed
01

Why it matters

The earnings release offers fresh data for traders to reassess valuation, especially given the mixed revenue and earnings trends.

02

Market read

Primary earnings disclosure with modest revenue miss and earnings beat; relevant for short‑term traders monitoring industrial stocks.

03

What to watch

Integration restructuring savings of $48M could improve margins in upcoming quarters.

Relevance 8/10Novelty 8/10Timing: post‑market today

Background

JBT Marel Corp (JBTM) filed its Q3 2026 10‑Q, providing the latest financial results and operational highlights.

Company-level read

Ticker impact

$JBTMNeutralHigh confidence
Context

Q3 2026 earnings released: revenue $994M (down 0.7%), net income $70M (up 6.1%), EPS $1.34 (up 6.3%).

Expected impact

potential modest move as investors weigh revenue dip against earnings beat

Evidence & confidence

The new 10‑Q provides fresh numbers; revenue miss may pressure the stock while EPS beat could support it.

Market effects

Signals slight slowdown in protein solutions demand, may affect other food‑processing equipment makers.

Limited to North American industrial equipment sector.

Low global impact; primarily a company‑specific earnings update.

Counterpoint

Revenue decline could be a warning sign; short sellers may target the stock despite earnings beat.

Key entities

  • JBT Marel Corp

    Industrial equipment manufacturer reporting Q3 2026 results.

Related articles

$JBTMHighAI 8/10

What JBT Marel (JBTM) Said on Its Q3 Earnings Call

JBT Marel (JBTM) reported Q3 adjusted EBITDA of $179M, up 5% YoY, with improved margins in both business segments. EPS rose 13% due to margin improvements and lower interest expense. The company generated $73M in free cash flow, repurchased 800,000 shares, and increased its repurchase authorization to $700M. JBTM revised its full-year revenue outlook down to $3.95B-$4B but raised adjusted EBITDA margin and EPS guidance.

$JBTMMed

JBT Marel Corp (JBTM) (Q3 2026) Earnings Call Highlights: Record Margins Offset by CPG

JBT Marel Corp (JBTM) reported Q3 2026 earnings, highlighting record margins offset by consumer packaged goods (CPG) softness. CEO Brian Deck mentioned opportunities from USDA line-speed rulings and targeted mid-teen margins for meat and fish businesses. CFO Matt Meister discussed buyback plans, maintaining leverage targets, and Q4 revenue growth expectations. The company also addressed supply chain challenges and M&A strategies.

Med

JBT Marel Corporation Q3 2026 Earnings Call Summary

JBT Marel Corporation reported Q3 2026 earnings with an 18% adjusted EBITDA margin, driven by cost improvements and automation demand in the Protein Solutions segment. Revenue in Prepared Food and Beverage declined due to lower volume. Management expects a 20% EBITDA margin by 2028 and revised full-year revenue guidance downward. The Board authorized a $700 million share repurchase program. Potential USDA poultry ruling could boost automation investments.

$JBTMMedAI 8/10

JBT Marel (JBTM) Q3 2026 Earnings Call Transcript

JBT Marel reported Q3 2026 revenue of $994M, down 1% YoY. Protein Solutions grew 6%, while Prepared Food and Beverage declined 6%. Adjusted EBITDA rose 5% to $179M. Full-year revenue guidance lowered to $3.95B-$4B, but EBITDA margin guidance increased to 17.25%-17.5%. The company repurchased $94M in shares and increased its buyback program to $700M. Management remains optimistic about demand, particularly in poultry, and expects USDA rulings to boost U.S. investments.

MedAI 8/10

JBT Marel Q3 2026 slides: record margins offset revenue miss

JBT Marel reported Q3 2026 revenue of $994M, missing expectations by $36M, but achieved record adjusted EBITDA of $179M with an 18% margin. Shares rose 2.76% to $117.95. The company raised full-year EBITDA margin and EPS guidance, citing cost synergies and share buybacks. Protein Solutions grew 6%, while Prepared Food and Beverage Solutions declined 6%.

$JBTMHigh

JBT Marel Corporation Reports Third Quarter 2026 Results and Announces Increased Share Repurchase Authorization Third Quarter 2026

JBT MAREL Corp (JBTM) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 News Release JBT Marel Corporation 333 West Wacker Drive Suite 3400 Chicago, IL 60606 JBT Marel Corporation Reports Third Quarter 2026 Results and Announces Increased Share Repurchase Authorization Third Quarter 2026 Highlights: ◦ Achieved net income margin of 7.0 pe